Clinical Studie of a Novel Hemolysis Point of Care Test at an Emergency Department.

2016-11-30 15:45:23 | BioPortfolio


This study aims to investigate the outcome of hemolysis frequency when a hemolysis point of care test is introduced in a emergency department.


In a blood sample process, the preanalytical phase is accountable for a vast majority of laboratory test errors. Among preanalytical errors, hemolysis is the most frequent error of sample rejection. Recollection of blood from the patient causes extra suffering, increased turn-around-time hence delayed treatment, and unnecessary extra costs for the health care system.

Here a novel method for hemolysis point of care detection (H-POCT) is evaluated. The singel ues test is attached to the blood sample in direct conjuction to the sampling process.

Patients will be selected by consecutive selection at the emergency department if blood tests ordered by the physician meet the inclusion criteria. Then randomized into one of two groups. All healthcare professionals participating in this study have attended in a standard education program in operating H-POCT and information regarding the study.

If Allocated into the control group, n: 750, nurses and enrolled nurses will perform blood sample according to routine.

If allocated into the intervention group, n: 750, nurses and enrolled nurses will perform blood sample according to routine and screen all Lithium Heparin vacuum tubes. (for one or all of the analyzes: Liver status, Electrolytes and Troponin T.)

If the hemolysis point of care test (H-poct)indicate a positive test result the Lithium Heparin vacuum tube and the attached H-poct will be discarded and a new sample will be collected and screened for hemolysis until the user receives a negative sample that is not hemolyzed.

This study takes place at the emergency department in Central hospital in Karlstad.

The hospital is a county hospital with 430 beds and the emergency department treats 59000 patients yearly.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label




Hemolysis Point-of-Care test


Emergency department, Central Hospital Karlstad


Enrolling by invitation


Hemcheck Sweden AB

Results (where available)

View Results


Published on BioPortfolio: 2016-11-30T15:45:23-0500

Clinical Trials [552 Associated Clinical Trials listed on BioPortfolio]

Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension

The primary hypothesis of this study is that glutamine supplementation will improve the erythrocyte glutamine/glutamate ratio, a biomarker of oxidative stress, hemolysis and pulmonary hype...

Sternal Intraosseous Transfusion of Autologous Whole Blood: A Comparison of Flow Rates and Degree of Hemolysis

In this study we investigate the impact of two CE marked and FDA approved sternal needles in comparison to intravenous access on the flow-rate of autologous reinfusion of whole blood and t...

Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis

The purpose of this research study is to more accurately measure the amount of true red blood cell breakdown (hemolysis) in newborn babies with potentially problematic blood type mismatch ...

Long Term Effects of Erythrocyte Lysis

In this prospective observational trial, participants with chronic hemolysis will be assessed with echocardiogram for elevated tricuspid jet velocity and other evidence of pulmonary hypert...

New Hemolysis Parameters in Sickle Cell Disease

The 6-minute walk (6MWT) test is used in adults and children affected by a wide range of chronic diseases to evaluate their sub-maximal exercise capacity. It reflects the global response o...

PubMed Articles [18410 Associated PubMed Articles listed on BioPortfolio]

Influence of In Vitro Hemolysis on 80 Different Laboratory Tests.

In vitro hemolysis is probably the most common pre-analytic problem in laboratory medicine. However, it introduces variation into results in unknown ways. Therefore, the purpose of this study was to a...

Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility.

Patients treated with intravenous immunoglobulins (IVIG) rarely experience symptomatic hemolysis. Although anti-A and anti-B isoagglutinins from the product are involved in most cases, the actual mech...

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method.

Hemolysis is the most common reason why coagulation test samples are rejected. However, the effects of hemolysis on plasma prothrombin time (PPT) and activated partial thromboplastin time (APTT) are r...

Effect of red blood cell storage time on markers of hemolysis and inflammation in transfused very low birth weight infants.

Prolonged storage of transfused red blood cells (RBCs) is associated with hemolysis in healthy adults and inflammation in animal models. We aimed to determine whether storage duration affects markers ...

Hemolysis During Open-Heart Surgery With Vacuum-Assisted Venous Drainage at Different Negative Pressures in Pediatric Patients Weighing Less Than 10 kilograms.

This study examined the degree of hemolysis during vacuum-assisted venous drainage at different negative pressures to identify an adequate negative pressure that provides effective venous drainage wit...

Medical and Biotech [MESH] Definitions

Exotoxins produced by certain strains of streptococci, particularly those of group A (STREPTOCOCCUS PYOGENES), that cause HEMOLYSIS.

The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Allows patient diagnoses in the physician’s office, in other ambulatory setting or at bedside. The results of care are timely, and allow rapid treatment to the patient. (from NIH Fact Sheet Point-of-Care Diagnostic Testing, 2010.)

The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS.

A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice.

More From BioPortfolio on "Clinical Studie of a Novel Hemolysis Point of Care Test at an Emergency Department."

Quick Search

Searches Linking to this Trial